10:00- 11:00 (GMT+01:00) Agenda Summary The goal of the webinar was to: Provide context to the the additive usage template by explaining why data on use of additives is needed. Describe the main features of the template and the information/data that is re ...
10:00- 11:00 (GMT+01:00) Agenda Summary The goal of the webinar was to explain the new aspects of the guidance on the assessment of the safety of feed additives for the target species. The focus was on the new approaches to provide evidence of safety of t ...
11:00- 12:00 (GMT+01:00) Agenda Summary The goal of the webinar was to: Present EFSA’s multicultural work environment; Clarify that the traineeship is open to candidates with different backgrounds – business, communication, HR specialists, scientists in a ...
Agenda Summary The goal of the webinar was to present the EFSA guidance document on allergenicity assessment of genetically modified (GM) plants and to clarify any aspect needing additional explanations. The webinar initiated with an overall presentatio ...
14:00- 15:00 (GMT+01:00) Agenda Summary The goal of the webinar was to help applicants to better understand the principles of the feed additives authorisation process and make their technical dossiers fit for purpose in the context of risk assessment, in ...
Rapid risk assessments are needed in the initial stage of a disease outbreak to help risk managers prepare and respond to possible health threats and to reduce the social and economic consequences of the threat. In this webinar, three rapid risk assessmen ...
Agenda (142.75 KB) Minutes (233.5 KB) Webinar Networks Novel food false ...
Documents Agenda (160 KB) Webinar false ...
Draft agenda is available here Webinar cancellation notice We regret to inform you that the webinar scheduled for 11 July on the explanatory note on next generation sequencing (NGS) in GMO applications is postponed until further notice. Additional fine-tu ...
12:30- 14:00 (GMT+01:00) Agenda Summary EFSA presented the key scientific issues regarding the required compositional and toxicological data as outlined in its guidance document on the preparation and presentation of an application for authorisation of a ...